About Early activation antigen CD69
Early activation antigen CD69 (CD69) is a protein
from Homo sapiens identified by UniProt accession
Q07108, 199 residues long.
MolForge cross-references it against 0 known binders and
646 disease associations.
Target properties
| Protein name | Early activation antigen CD69 |
|---|
| UniProt accession | Q07108 |
|---|
| Gene | CD69 |
|---|
| Organism | Homo sapiens |
|---|
| Length | 199 residues |
|---|
| Molecular weight | — |
|---|
| EC numbers | — |
|---|
| Target class | UNCLASSIFIED |
|---|
| Subcellular location | — |
|---|
| Keywords | — |
|---|
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
|---|
| Druggability score | — |
|---|
| Pocket score | — |
|---|
| Max clinical phase | — |
|---|
Disease associations (646)
Diseases linked to this target (Open Targets).
- lymphocyte count · score 0.47
- lymphocyte percentage of leukocytes · score 0.44
- leukocyte count · score 0.43
- hypothyroidism · score 0.41
- myeloid white cell count · score 0.40
- monocyte percentage of leukocytes · score 0.40
- neutrophil percentage of leukocytes · score 0.39
- Hashimoto's thyroiditis · score 0.36
- type 1 diabetes mellitus · score 0.33
- thyroid disease · score 0.33
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
|---|
| AF-Q07108-F1 | alphafold | PREDICTED | 82.14 | — |
Amino-acid sequence (199 residues)
MSSENCFVAE NSSLHPESGQ ENDATSPHFS TRHEGSFQVP VLCAVMNVVF ITILIIALIA LSVGQYNCPG QYTFSMPSDS HVSSCSEDWV GYQRKCYFIS TVKRSWTSAQ NACSEHGATL AVIDSEKDMN FLKRYAGREE HWVGLKKEPG HPWKWSNGKE FNNWFNVTGS DKCVFLKNTE VSSMECEKNL YWICNKPYK
Explore Early activation antigen CD69 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets